Open AccessWeek 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Author(s) -
J.J. Eron,
C. Orkin,
D. Cunningham,
F. Pulido,
F.A. Post,
S. De Wit,
E. Lathouwers,
V. Hufkens,
B. Vandercam,
J. Jezorwski,
R. Petrovic,
K. Brown,
E. Van Landuyt,
M. Opsomer,
S. De Wit,
E. Florence,
M. Moutschen,
E. Van Wijngaerden,
L. Vandekerckhove,
J. Brunetta,
B. Conway,
M. Klein,
D. Murphy,
A. Rachlis,
S. Shafran,
S. Walmsley,
F. Ajana,
L. Cotte,
P.-M. Girardy,
C. Katlama,
J.-M. Molina,
I. Poizot-Martin,
F. Raffi,
D. Rey,
J. Reynes,
E. Teicher,
Y. Yazdanpanah,
J. Gasiorowski,
W. Halota,
A. Horban,
A. Piekarska,
A. Witor,
J.R. Arribas,
I. Perez-Valero,
J. Berenguer,
J. Casado,
J.M. Gatell,
F. Gutierrez,
M.J. Galindo,
M.D.M. Gutierrez,
J.A. Iribarren,
H. Knobel,
E. Negredo,
J.A. Pineda,
D. Podzamczer,
J.P. Sogorb,
F. Pulido,
C. Ricart,
A. Rivero,
I. Santos Gil,
A. Blaxhult,
L. Flamholc,
M. Gisslen,
A. Thalme,
J. Fehr,
A. Rauch,
M. Stoeckle,
A. Clarke,
B.G. Gazzard,
Melina Johnson,
C. Orkin,
F. Post,
A. Ustianowski,
L. Waters,
J. Bailey,
P. Benson,
L. Bhatti,
I. Brar,
U.F. Bredeek,
C. Brinson,
G. Crofoot,
D. Cunningham,
E. DeJesus,
C. Dietz,
R. Dretler,
J. Eron,
F. Felizarta,
C. Fichtenbaum,
J. Gallant,
J. Gathe,
D. Hagins,
S. Henn,
W.K. Henry,
G. Huhn,
M. Jain,
C. Lucasti,
Catalina Puigserver Martorell,
C. McDonald,
A. Mills,
J. Morales-Ramirez,
K. Mounzer,
R. Nahass,
H. Olivet,
O. Osiyemi,
D. Prelutsky,
M. Ramgopal,
B. Rashbaum,
G. Richmond,
P. Ruane,
A. Scarsella,
A. Scribner,
P. Shalit,
D. Shamblaw,
J. Slim,
K. Tashima,
GENE VOSKUHL,
D. Ward,
A. Wilkin,
J. de Vente,
EMERALD study group
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/pn34-7p83
Subject(s) - emtricitabine , tenofovir , randomized controlled trial , medicine , emerald , pharmacology , chemistry , virology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load , mineralogy